Business
Press Release Jan 13 2026
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 13, 2026, titled "Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 13, 2026, titled \"Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)\". View Attachment","length":336,"tagName":"div"}]